Hypophosphatemia clinical trials

The registry lists 69 studies for Hypophosphatemia across more than 10 countries. 15 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-21.

Studies

Recruiting first, then most recently updated. Showing 50 of 69 — search for more.

• A First-in-human Study of KK8123 in Adults With X-linked HypophosphatemiaRecruitingNCT06525636Phase 1/25 countries
• Respiratory Quotient and Phosphate Changes During Early Critical IllnessNot yet recruitingNCT07800143
• Phosphate in Acute PancreatitisRecruitingNCT07681050Phase 21 country
• Phosphorus-31 Spectroscopy in Phosphate DiabetesRecruitingNCT06921720Not applicable1 country
• Morphology in Oral Rare Syndromes & Artificial Intelligence for Clinical DiagnosisNot yet recruitingNCT07666269Not applicable1 country
• Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant RecipientsRecruitingNCT06824454Phase 21 country
• The Impact of Phosphate Metabolism on Healthy AgingRecruitingNCT03771105Early Phase 11 country
• Effective Dosing of Burosumab in XLHRecruitingNCT071835791 country
• Protocolised Management of Phosphate Replacement TrialNot yet recruitingNCT07288944Not applicable
• Enteral Supplementation With Sodium Dihydrogen Phosphate and Disodium Hydrogen Phosphate Granules for the Treatment of Hypophosphatemia.RecruitingNCT07233889Not applicable1 country
• Expanded Access to BurosumabAvailableNCT03775187
• Effect of Hypophosphatemia on Neuro-excursion Efficiency During Mechanical Ventilator WeaningRecruitingNCT067546701 country
• IV Iron-induced Hypophosphatemia After RYGBRecruitingNCT06350955Phase 41 country
• National Registry of Rare Kidney DiseasesRecruitingNCT060658521 country
• Prevention of Spontaneous Dental Abscesses in Children With X-linked Hypophosphatemia : a RCTNot yet recruitingNCT04872907Phase 3
• X-linked Hypophosphatemia Disease Monitoring ProgramActive, not recruitingNCT036515056 countries
• The Efficacy and Safety of Diluted Oral Phosphate Enema Versus Intravenous Sodium Glycerophosphate in The Treatment of Hypophosphatemia in ICU PatientsCompletedNCT06651892Phase 2/31 country
• Metabolic Pathway Analysis in Intensive Care Unit Patients With Refeeding SyndromeCompletedNCT063445463 countries
• Validation of the GIDS and Description of Phosphate DisordersCompletedNCT059097221 country
• Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Patients Less Than 1 Year of AgeCompletedNCT04188964Phase 1/26 countries
• A UK Multicentre, Health-Related Quality of Life Study for Children and Adolescents With XLHCompletedNCT048194901 country
• Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Pediatric Chinese Patients With XLHCompletedNCT04842032Phase 41 country
• Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With XLHCompletedNCT04842019Phase 41 country
• An Extension Study of KRN23 in Adults With X-Linked HypophosphatemiaCompletedNCT01571596Phase 1/22 countries
• A Repeated Study of KRN23 in Adults With X-Linked HypophosphatemiaCompletedNCT01340482Phase 1/22 countries
• Study of KRN23 in Adults With X-linked Hypophosphatemia (XLH)CompletedNCT02526160Phase 37 countries
• Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)CompletedNCT02537431Phase 36 countries
• A Study of KRN23 in X-linked HypophosphatemiaCompletedNCT00830674Phase 11 country
• Study of the Safety, Pharmacodynamics (PD) and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH)CompletedNCT02750618Phase 21 country
• Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH)CompletedNCT02312687Phase 21 country
• Characterising Pain, QoL, Body Composition, Arterial Stiffness, Muscles and Bones in Adult Persons With XLH and Healthy ControlsCompletedNCT042734901 country
• Effects of Treatments for Anemia and Iron Deficiency on the Electrolyte Balance in Lung Transplant Recipients: A Special Focus on HypophosphatemiaActive, not recruitingNCT061122361 country
• Newborn Phosphocalcic Metabolism After Intravenous Iron Administration During PregnancyCompletedNCT061082581 country
• Retrospective and Prospective Disease Progression and Quality of Life in XLHCompletedNCT040498771 country
• Foot Disorders in X-linked HypophosphatemiaCompletedNCT060679321 country
• Examining the Effect of Burosumab on Muscle FunctionCompletedNCT04146935Phase 41 country
• Ferric Carboxymaltose With or Without Phosphate Substitution for the Treatment of Iron Deficiency or Iron Deficiency AnemiaCompletedNCT05098249Phase 41 country
• Study of the Inappropriate Secretion of FGF23 in Patients Followed in Hospital in a Context of HypophosphatemiaCompletedNCT048466471 country
• Anti-FGF23 (Burosumab) in Adult Patients With XLHCompletedNCT04695860Phase 31 country
• Biomarker for Cystinosis Disease: BioCystinosis (BioCystinosis)WithdrawnNCT028375233 countries
• FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP)CompletedNCT034899931 country
• Dental Implants in Patients With X-linked HypophosphatemiaStatus unknownNCT038799151 country
• Study of the Anti-FGF23 Antibody, Burosumab, in Adults With XLHCompletedNCT03920072Phase 34 countries
• Using Cinacalcet to Treat the Hypophosphatemia of Early Kidney TransplantTerminatedNCT01011114Not applicable1 country
• Hypophosphatemia and BronchiolitisStatus unknownNCT048146411 country
• A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Due to Inflammatory Bowel DiseaseCompletedNCT03466983Phase 41 country
• HYPOPhosphatemia in the Intensive Care: A One-day Point Prevalence SurveyCompletedNCT042018993 countries
• X-linked Hypophosphatemia and FGF21CompletedNCT035965541 country
• Levels of 'Hypophosphatemia Affect Outcome of Septic Patients in ICUStatus unknownNCT04519762Phase 4
• Investigation of Hypophosphataemia Following Intravenous IronStatus unknownNCT045027841 country